Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands

References

1. Bell, J. M., Mathai, D., Jones, R. N. & Turnidge, J. D. (2009 Emergence of OXA-48 carbapenemases among Klebsiella spp. from India. In: Abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), abstract C2–650. Washington, DC: American Society for Microbiology
2. Bradford P. A., Urban C., Mariano N., Projan S. J., Rahal J. J., Bush K. 1997; Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563–569[PubMed]
   [Google Scholar]
3. Castanheira M., Deshpande L. M., Mathai D., Bell J. M., Jones R. N., Mendes R. E. 2011; Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program (2006–2007). Antimicrob Agents Chemother (in press) [PubMed]
   [Google Scholar]
4. Cuzon G., Naas T., Bogaerts P., Glupczynski Y., Huang T. D., Nordmann P. 2008a; Plasmid-encoded carbapenem-hydrolyzing β-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrob Agents Chemother 52:3463–3464 [View Article][PubMed]
   [Google Scholar]
5. Cuzon G., Naas T., Demachy M. C., Nordmann P. 2008b; Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797 [View Article][PubMed]
   [Google Scholar]
6. Livermore D. M. 2009; Has the era of untreatable infections arrived?. J Antimicrob Chemother 64:Suppl. 1i29–i36 [View Article][PubMed]
   [Google Scholar]
7. Poirel L., Héritier C., Tolün V., Nordmann P. 2004; Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22 [View Article][PubMed]
   [Google Scholar]
8. Poirel L., Pitout J. D., Nordmann P. 2007; Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2:501–512 [View Article][PubMed]
   [Google Scholar]
9. Poirel L., Ros A., Carricajo A., Berthelot P., Pozzetto B., Bernabeu S., Nordmann P. 2011; Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–448 [View Article][PubMed]
   [Google Scholar]